<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39380503</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1362-4962</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>09</Day></PubDate></JournalIssue><Title>Nucleic acids research</Title><ISOAbbreviation>Nucleic Acids Res</ISOAbbreviation></Journal><ArticleTitle>A compact stem-loop DNA aptamer targets a uracil-binding pocket in the SARS-CoV-2 nucleocapsid RNA-binding domain.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">gkae874</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/nar/gkae874</ELocationID><Abstract><AbstractText>SARS-CoV-2 nucleocapsid (N) protein is a structural component of the virus with essential roles in the replication and packaging of the viral RNA genome. The N protein is also an important target of COVID-19 antigen tests and a promising vaccine candidate along with the spike protein. Here, we report a compact stem-loop DNA aptamer that binds tightly to the N-terminal RNA-binding domain of SARS-CoV-2 N protein. Crystallographic analysis shows that a hexanucleotide DNA motif (5'-TCGGAT-3') of the aptamer fits into a positively charged concave surface of N-NTD and engages essential RNA-binding residues including Tyr109, which mediates a sequence-specific interaction in a uracil-binding pocket. Avid binding of the DNA aptamer allows isolation and sensitive detection of full-length N protein from crude cell lysates, demonstrating its selectivity and utility in biochemical applications. We further designed a chemically modified DNA aptamer and used it as a probe to examine the interaction of N-NTD with various RNA motifs, which revealed a strong preference for uridine-rich sequences. Our studies provide a high-affinity chemical probe for the SARS-CoV-2 N protein RNA-binding domain, which may be useful for diagnostic applications and investigating novel antiviral agents.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press on behalf of Nucleic Acids Research.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Esler</LastName><ForeName>Morgan A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belica</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rollie</LastName><ForeName>Joseph A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>William L</ForeName><Initials>WL</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghadasi</LastName><ForeName>Seyed Arad</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harki</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicinal Chemistry, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Reuben S</ForeName><Initials>RS</Initials><Identifier Source="ORCID">0000-0002-9034-9112</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX 78229, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX 78229, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aihara</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-7508-6230</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Molecular Virology, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 CA234228</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R35 GM118047</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI171954</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>NIGMS R35-GM118047</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nucleic Acids Res</MedlineTA><NlmUniqueID>0411011</NlmUniqueID><ISSNLinking>0305-1048</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>9</Day><Hour>4</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39380503</ArticleId><ArticleId IdType="doi">10.1093/nar/gkae874</ArticleId><ArticleId IdType="pii">7815981</ArticleId></ArticleIdList></PubmedData></PubmedArticle>